Abstract
Recently, the impact on kidney function of hemodynamic factors (e.g., blood pressure), metabolic variables (e.g., blood glucose), vasoactive hormones (e.g., prostaglandins, angiotensin II), and protein loading or restriction has been elucidated in diabetic animals and man. This chapter reviews the influence of blood pressure, prostaglandins, and angiotensin II on urinary albumin excretion and glomerular filtration rate (GFR) in insulin-dependent diabetes mellitus (IDDM) patients with incipient and overt diabetic nephropathy.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Mogensen CE: Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 285: 685–688, 1982.
Parving H-H, Andersen AR, Smidt UM, Svendsen PAa: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1: 1175–1179, 1983.
Parving H-H, Andersen AR, Smidt UM, Hommel E, Mathiesen E: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 294: 1443–1447, 1987.
Parving H-H, Andersen AR, Smidt UM,’ Friisberg B, Svendsen PAa: Reduced albuminuria during early and aggression antihypertensive treatment of insulin-dependent diabetics with diabetic nephropathy. Diabetes Care 4: 459–463, 1981.
Parving H-H, Kastrup J, Smidt UM, Andersen AR, Feldt-Rasmussen B, Christiansen JS: Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 27: 547–552, 1984.
Hommel E, Mathiesen E, Edsberg B, Bahnsen M, Parving H-H: Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia 29: 211–215, 1986.
Azar S, Mauer SM, Azar P: Effect of mesangial expansion on renal hemodynamics and auto-regulation of renal blood flow [abstr]. Kidney !nt 25: 209, 1984.
Parving H-H, Oxenbell B, Svendsen PAa, Christiansen JS, Andersen AR: Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) 100: 550–555, 1982.
Viberti GC, Hill RD, Jarrett RJ, Argyropaulos A, Mahmud Y, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1: 1430–1432, 1982.
Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311: 89–93, 1984.
Mathiesen ER, Oxenbell B, Johansen K, Svendsen PAa, Deckert T: Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26: 406–410, 1984.
Hricik DE, Browning PJ, Koppelman R, Goorno WE, Madias NE, Dzau VJ: (1983) Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenosis or renal-artery stenosis in a solitary kidney. N Engl J Med 308: 373–376, 1983.
Curtis JJ, Luke RG, Whetchel JD, Diethelm AD, Jones P, Dustan HR: Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension. N Engl J Med 308: 377–381, 1983.
Blythe WB: Captopril and renal autoregulation. N Engl J Med 308: 390–391, 1983.
Bohrer MP, Dean WM, Robertson CR, Brenner BM: Mechanism of angiotensin Il-induced proteinuria in the rat. Am J Physiol 233: F13–21, 1977.
Taguma Y, Kilamoto Y, Futaki G, Ueda H, Momma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y: Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617–1620, 1985.
Björck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M: Beneficial effects on angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 293: 471–474, 1986.
Hommel E, Parving H-H, Mathiesen E, Edsberg B, Nielsen MD, Giese J: Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467–470, 1986.
O’Hare JA: Effect of captopril on diabetic proteinuria [letter]. N Engl J Med 315: 515, 1986.
Sridhar CB: Effect of captopril on diabetic proteinuria [letter] N Engl J Med 315: 515, 1986.
Arisz L, Donker AJM, Brentjens JRH, van der Hem GN: The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome. Acta Med Scand 199: 121–125, 1976.
Kimberly RP, Gill JR, Bowden RE, Keiser HR, Plotz PH: Elevated urinary prostaglandins and the effect of aspirin on renal function in lupus erythematosus. Ann Intern Med 89: 336–341, 1978.
Tiggeler RGWL, Hulme B, Wifdeveld PGAB: Effect of indomethacin on glomerular permeability in the nephrotic syndrome. Kidney Int 16: 312–321, 1979.
Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C: Effects of sulindac and ibuprofen in patients with chronic glomerular disease. N Engl J Med 310: 279–283, 1984.
Hommel E, Mathiesen E, Arnold-Larsen S, Edsberg B, Olsen UB, Parving H-H: Effects of indomethacin on kidney function in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 30: 78–81, 1987.
Mathiesen ER, Hommel E, Olsen UB, Parving H-H: Effects of indomethacin on kidney function in insulin-dependent diabetic patients with incipient nephropathy [abstr]. Diabetologia 29: 569A, 1986.
Jensen PK, Steven K, Blæhr H, Christiansen JS, Parving H-H: Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29: 490–495, 1986.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Parving, HH., Hommel, E., Mathiesen, E. (1988). Acute Modulation of Renal Function in Microalbuminuric and Macroalbuminuric Insulin-Dependent Diabetic Patients. In: Mogensen, C.E. (eds) The Kidney and Hypertension in Diabetes Mellitus. Topics in Renal Medicine, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1974-1_21
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1974-1_21
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1976-5
Online ISBN: 978-1-4757-1974-1
eBook Packages: Springer Book Archive